Cargando…
The quest for a biomarker of circulating osteoclast precursors
Osteoclast precursors arise from the CD14+ CD16- population in controls but details about cell surface marker expression and functional characteristics of these cells is unknown, particularly in patients with inflammatory arthritis. In a recent issue of Arthritis, Research and Therapy, Lari and coll...
Autor principal: | Ritchlin, Christopher |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714124/ https://www.ncbi.nlm.nih.gov/pubmed/19591635 http://dx.doi.org/10.1186/ar2707 |
Ejemplares similares
-
Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors
por: Perpétuo, Inês P., et al.
Publicado: (2017) -
TAS-102 and the quest for predictive biomarkers
por: van der Velden, Daphne L, et al.
Publicado: (2017) -
The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017) -
CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
por: Chiu, Yahui Grace, et al.
Publicado: (2010) -
Corrigendum: Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors
por: Perpétuo, Inês P., et al.
Publicado: (2017)